Comparative simulation of intraperitoneal aminoglycoside regimens for patients with peritonitis on automated peritoneal dialysis.
Robert E ArianoSheryl A ZelenitskyChristine DavisChristie SathianathanWilliam R WolowichPublished in: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2024)
The current international guidelines for the treatment of peritoneal dialysis-associated peritonitis can continue to recommend the fixed-dose regimen for those on APD with the addition of plasma Cmin monitoring after 3 days to assess for drug accumulation.